Skip to main content
SpringerLink
Log in

DDW-Kongress 2018 in Washington DC — Teil 3

Die aktuellen Studien zu Kolon, — Dünndarm und CED

  • aktuell
  • Published:
Gastro-News Aims and scope

Die chronisch entzündlichen Darmerkrankungen waren wie in den vergangenen Jahren das größte Thema auf dem amerikanischen Gastroenterologenkongress (DDW). Daneben gab es aber auch wichtige wissenschaftlichen Erkenntnisse zu den sonstigen Darmerkrankungen einschließlich der funktionellen Störungen. In einer Serie von Artikeln werden in GASTRO NEWS die Inhalte der wichtigsten Vorträge und Abstracts präsentiert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Mahadev S et al. Gastroenterology 2018; 154(6) Suppl1: Mo1035

    Article  Google Scholar 

  2. Fan C et al. Gastroenterology 2018; 154(6) Suppl1: Sa1081

    Google Scholar 

  3. Iacovou M et al. Gastroenterology 2018; 154(6) Suppl1: Sa2003

    Article  Google Scholar 

  4. Wilkinson-Smith V et al. Gastroenterology 2018; 154(6), Suppl 1: Mo1053

    Google Scholar 

  5. Eady et al. Gastroenterology 2018; 154(6) Suppl1: Su1189

    Article  Google Scholar 

  6. Cremon C et al. Gastroenterology 2018; 154(6), Suppl 1: Su1659

    Google Scholar 

  7. Du et al. Gastroenterology 2018; 154 (6) Suppl1: LB Tu2017

    Google Scholar 

  8. Botschuijver S et al. Gastroenterology 2018; 154(6), Suppl 1: OP643

    Article  Google Scholar 

  9. Manssor et al. Gastroenterology 2018;154(6), Suppl 1:Mo1617

    Google Scholar 

  10. Ohri A et al. Gastroenterology 2018; 154(6) Suppl1: Sa1634

    Google Scholar 

  11. Vuik FE et al. Gastroenterology 2018; 154(6) Suppl1: Sa1635

    Article  Google Scholar 

  12. Vasopelli R, Kerstin Schuette K, Schulz K et al. Distinct microbiotica communities along the entire human digestive tract. Gastroenterology 2018; 154 (6) Suppl1: Su1950

    Google Scholar 

  13. Bharat M, Curran J, Herfarth HH et al. SER-287, an investigational microbiome therapeutic, induces remission and endoscopic improvement in placebo controlled, double-blind randomized trial in patients with active mild-to-moderate ulcerative colitis. Gastroenterology 2018; 154(6) Suppl 1: LB OP85

    Article  Google Scholar 

  14. Simpson HL, Campbell BJ. Dietary fibre - microbiotica interactions. Aliment Pharmacol Therapeut 2015: 42(2): 158–179

    Article  CAS  Google Scholar 

  15. Schreiner P, Yilmaz B, Franc Y et al. Vegetarian and gluten-free diet in patients with IBD - associated with a different microbiotica compared to omnivore IBD patients. Gastroenterology 2018; 154(6) Suppl 1: Sa1864

    Article  Google Scholar 

  16. Costello SP, Soo W, Bryant R V. et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther 2017. doi: https://doi.org/10.1111/apt.14173

    Google Scholar 

  17. Holvoet T, Joossens M, Jerina B et al. Fecal microbiota transplantation in irritable bowel syndrome with predominant abdominal bloating: results from a double blind, placebo-controlled clinical trial. Gastroenterology 2018; 154(6) Suppl1: OP617

    Article  Google Scholar 

  18. Cammarota G, Ianiro G, Tilg H et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017. doi: https://doi.org/10.1136/gutjnl-2016-313017

    Google Scholar 

  19. Pariente B, Cosnes J, Danese S et al. Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011. doi: https://doi.org/10.1002/ibd.21506

    Google Scholar 

  20. Colombel JF, Panaccione R, Bossuyt P et al. Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet 2017. doi: https://doi.org/10.1016/S0140-6736(17)32641-7

    Google Scholar 

  21. Ungaro R, Colombel F, Patel A et al. Net remission rates with biologic treatment in Crohn’s diesease: a reappraisal of the clinical data adjusting for both induction and remission phases and prior exposure to TNF-antagonists. Gastroenterology 2018; 154(6) Suppl1: Mo 1035

    Google Scholar 

  22. Kucharzik, Torsten; Dignass, Axel U; Atreya A et al. Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2018; 56:1087–1169

    Article  Google Scholar 

  23. Dreesen E, D’Haens GR, Baert F et al. Infliximab exposure predicts superior endoscopic outcomes in patients with active Crohn’s disease: pharmacokinetic-pharmacodynamic analysis of TAILORIX. Gastroenterology 2018; 154(6) Suppl 1: Mo1841

    Google Scholar 

  24. Singh N, Arora Y, Yakub J et al. Infliximab trough levels predict one year persistent remission in infliximab-treated pediatric IBD patients. Gastroenterology 2018; 154(6) Suppl1: Mo1851

    Google Scholar 

  25. Syal G, Robbins L, Kashani A et al. Hypalbuminemia and bandemia predict failure of infliximab rescue therapy in acute severe colitis independent of the infliximab dose. Gastroenterology 2018; 154(6) Suppl1: Mo1891

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GFO Klinikum Bonn, St. Josef Hospital, Hermannstraße 37, 53225, Bonn, Deutschland

    Birgit Terjung

  2. Internistisches Klinikum München Süd, Am Isarkanal 36, 81379, München, Deutschland

    Manfred Gross

Authors
  1. Birgit Terjung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manfred Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Birgit Terjung.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Terjung, B., Gross, M. Die aktuellen Studien zu Kolon, — Dünndarm und CED. Gastro-News 5, 52–57 (2018). https://doi.org/10.1007/s15036-018-0507-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-018-0507-y

Search

Navigation